tiprankstipranks
Akero Therapeutics Inc (DE:0K4)
FRANKFURT:0K4
Germany Market

Akero Therapeutics (0K4) Income Statement

Compare
2 Followers

Akero Therapeutics Income Statement

Last quarter (Q4 2024), Akero Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Akero Therapeutics's net income was $-70.02M. See Akero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -29.00K$ -260.00K$ -244.00K$ -213.00K
Operating Expenses
$ 285.42M$ 172.87M$ 115.16M$ 100.89M$ 80.15M
Depreciation and Amortization
$ 0.00$ 29.00K$ 260.00K$ 244.00K$ 213.00K
EBITDA
$ -285.42M$ -148.63M$ -111.03M$ -100.53M$ -78.99M
Operating Income
$ -285.42M$ -172.87M$ -115.16M$ -100.89M$ -80.15M
Other Income/Expenses
$ 33.36M$ 21.11M$ 3.12M$ 109.00K$ 947.00K
Pretax Income
$ -252.06M$ -151.76M$ -112.03M$ -100.78M$ -79.21M
Net Income
$ -252.06M$ -151.76M$ -108.91M$ -100.74M$ -79.19M
Per Share Metrics
Basic EPS
$ -3.75$ -2.89$ -2.79$ -2.89$ -2.52
Diluted EPS
$ -3.75$ -2.89$ -2.79$ -2.89$ -2.52
Weighted Average Shares Outstanding
67.14M 52.57M 38.98M 34.83M 31.46M
Weighted Average Shares Outstanding (Diluted)
67.14M 52.57M 38.98M 34.83M 31.46M
Currency in USD

Akero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis